Fund Holdings — SR ONE CAPITAL MANAGEMENT, LP

Total Portfolio Value
$238.16M
Total Bought
$0
Total Sold
$37.06M
Net Transaction
-$37.06M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
ARCELLX INC.
COMMON STOCK
3,946,6303,146,630-800,000141,605174,63873.33%+33,033
NKARTA INC.(NKTX)1,333,3331,333,33301,8538,8003.70%+6,947
ARS PHARMACEUTICALS(SPRY)4,012,9034,012,903015,16921,9919.23%+6,822
DESIGN THERAPEUTICS INC(DSGN)6,526,4766,526,476015,40217,2957.26%+1,893
MINERALYS THERAPEUTICS(MLYS)1,794,6001,794,600017,06715,4346.48%-1,633
EFFECTOR THERAPEUTICS INC6,822,1140-6,822,1144,0250—-4,025
Page 1 of 1
SR ONE CAPITAL MANAGEMENT, LP — 13F Holdings — Q4 2023 | TickerTrail